Literature DB >> 14576378

Effect of age on clinical and morphological characteristics in patients with brain arteriovenous malformation.

C Stapf1, A V Khaw, R R Sciacca, C Hofmeister, H C Schumacher, J Pile-Spellman, H Mast, J P Mohr, A Hartmann.   

Abstract

BACKGROUND AND
PURPOSE: The goal of this work was to determine the effect of age at initial presentation on clinical and morphological characteristics in patients with brain arteriovenous malformation (AVM).
METHODS: The 542 consecutive patients from the prospective Columbia AVM database (mean+/-SD age, 34+/-15 years) were analyzed. Univariate statistical models were used to test the effect of age at initial presentation on clinical (AVM hemorrhage, seizures, headaches, neurological deficit, other/asymptomatic) and morphological (AVM size, venous drainage pattern, AVM brain location, concurrent arterial aneurysms) characteristics.
RESULTS: Hemorrhage was the presenting symptom in 46% (n=247); 29% (n=155) presented with seizures, 13% (n=71) with headaches, 7% (n=36) with a neurological deficit, and 6% (n=33) without AVM-related symptoms. Increasing age correlated positively with intracranial hemorrhage (P=0.001), focal neurological deficits (P=0.007), infratentorial AVMs (P<0.001), and concurrent arterial aneurysms (P<0.001); an inverse correlation was found with seizures (P<0.001), AVM size (P=0.001), and lobar (P<0.001), deep (P=0.008), and borderzone (P=0.014) location. No age differences were found for sex, headache, asymptomatic presentation, and venous drainage pattern.
CONCLUSIONS: Our data suggest a significant interaction of patient age and clinical and morphological AVM features and argue against uniform AVM characteristics across different age classes at initial presentation. In particular, AVM patients diagnosed at a higher age show a higher fraction of AVM hemorrhage and are more likely to harbor additional risk factors such as concurrent arterial aneurysms and small AVM diameter. Longitudinal population-based AVM data are necessary to confirm these findings.

Entities:  

Mesh:

Year:  2003        PMID: 14576378     DOI: 10.1161/01.STR.0000094824.03372.9B

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  17 in total

1.  Endovascular treatment accounts for a change in brain arteriovenous malformation natural history risk.

Authors:  X Lv; Z Wu; C Jiang; Y Li; X Yang; Y Zhang; M Lv; N Zhang
Journal:  Interv Neuroradiol       Date:  2010-07-19       Impact factor: 1.610

2.  Endovascular treatment of intracerebral arteriovenous malformations: procedural safety, complications, and results evaluated by MR imaging, including diffusion and perfusion imaging.

Authors:  M Cronqvist; R Wirestam; B Ramgren; L Brandt; B Romner; O Nilsson; H Säveland; S Holtås; E-M Larsson
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

3.  Management of brain arteriovenous malformations.

Authors:  Sherri A Braksick; Jennifer E Fugate
Journal:  Curr Treat Options Neurol       Date:  2015-07       Impact factor: 3.598

Review 4.  Treatment of arteriovenous malformations of the brain.

Authors:  Andreas Hartmann; Henning Mast; Jae H Choi; Christian Stapf; Jay P Mohr
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

5.  Endovascular treatment of cerebral arteriovenous malformations with emphasis on the curative role of embolisation.

Authors:  A Valavanis; A Pangalu; M Tanaka
Journal:  Interv Neuroradiol       Date:  2005-10-27       Impact factor: 1.610

6.  Periventricular Location as a Risk Factor for Hemorrhage and Severe Clinical Presentation in Pediatric Patients with Untreated Brain Arteriovenous Malformations.

Authors:  L Ma; Z Huang; X-L Chen; J Ma; X-J Liu; H Wang; X Ye; S-L Wang; Y Cao; S Wang; Y-L Zhao; J-Z Zhao
Journal:  AJNR Am J Neuroradiol       Date:  2015-06-18       Impact factor: 3.825

Review 7.  Differential diagnosis of nontraumatic intracerebral hemorrhage.

Authors:  Jennifer Linn; Hartmut Brückmann
Journal:  Klin Neuroradiol       Date:  2009-05-15

Review 8.  Pain management in neurocritical care.

Authors:  Axel Petzold; Armand Girbes
Journal:  Neurocrit Care       Date:  2013-10       Impact factor: 3.210

9.  Clinical and morphological determinants of focal neurological deficits in patients with unruptured brain arteriovenous malformation.

Authors:  J H Choi; H Mast; A Hartmann; R S Marshall; J Pile-Spellman; J P Mohr; C Stapf
Journal:  J Neurol Sci       Date:  2009-09-03       Impact factor: 3.181

10.  Seizure risk from cavernous or arteriovenous malformations: prospective population-based study.

Authors:  C B Josephson; J-P Leach; R Duncan; R C Roberts; C E Counsell; R Al-Shahi Salman
Journal:  Neurology       Date:  2011-05-03       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.